A Sincere Journey for Humanity's Life Without Most of Diseases

Since its establishment in 1988, CHO-A Pharmaceutical has established a production factory in Haman, Gyeongsangnam-do Province and continued to invest in improving quality standards and maximizing production capacity on the strengths of being approved as a KGMP (Korean Good Manufacturing Practice) qualified company in February 1995, obtaining ISO 9001 (quality standards of International Organization for Standardization) certification for the first time in the domestic pharmaceutical industry in May 1996, and obtaining GMP certification for health functional foods in May 2008. CHO-A Pharmaceutical, which has grown rapidly over the past 30 years, publicly registered on KOSDAQ in August 1999 based on its management performance so far, renewing itself as a more reputable company.

In 2023, CHO-A Pharmaceutical launched a safer and more convenient one-touch ampoule, ‘Cho-a Safeasy Ampoule’, while securing domestic and international patents. The safety and convenience of liquid products have been improved by applying the patented container ‘Cho-a Safeasy Ampoule’. The “Safeasy Ampoule” is a container using the portmanteau of 'safe and easy', and is made of the highest safety grade (USP Plastic Class VI) material certified by United States Pharmacopoeia. In addition, ‘Cho-a Safeasy Ampoule’ has acquired a domestic patent for its original design and ergonomic design that allows for better grip, and has filed patent applications in 12 overseas countries (USA, Europe, Japan, China, Vietnam, Indonesia, Malaysia, Cambodia, Peru, Kuwait, Guatemala, Saudi Arabia). In addition to durability and heat resistance, the double-protection effect from external shock through the installation of a sleeve enhances the durability of the product and minimizes damage from external shock. Besides that, it blocks the inflow of external foreign substances, and also improves safety by minimizing the degradation of ingredients with a light-shielding container, and its one-touch design enables easy opening, making it convenient to use anytime, anywhere.

Difference in Quality Recognized Overseas by Establishing a Research & Development System

To proactively respond to the rapidly changing global pharmaceutical market with both technological and social approaches, CHO-A Pharmaceutical boldly shifted its research and development domain from the existing first-generation biopharmaceutical research and development to the development of natural medicines based Yangbyeonghak theory [p1] in November 2020. Currently, the establishment of a research and development system has been completed with the goal of developing individually approved health functional food ingredients and natural medicines. In addition, CHO-A Pharmaceutical is kickstarting its entry into the global market by developing various new products and conducting research activities as well as establishing overseas branches to boldly enter the global market beyond the domestic market. It participates in overseas pharmaceutical and health functional food international trade exhibitions every year and is continuously working to develop the global market, pursue marketing, and increase exports.

In addition, contracts were signed to supply Jalkton, Lactobacillus Chewable, and Dino Lactobacillus Powder, which are helpful for children's growth, in line with the needs of the Hong Kong buyer. Under the export support of the Korea International Trade Association, CHO-A Pharmaceutical and the Hong Kong buyer have developed into important partners by continuously researching new products and developing and supplying products catering to the targeted market. Currently, the two companies still plan to cooperate to discover ingredients from third countries and develop new products catering to Hong Kong-based customers. It will continue to develop and maintain a strong partnership with the Hong Kong buyer through seamlessly constant communication.